Back to search
FDAFDA · Food and drugs·Recall number D-0752-2022

Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06

Published April 13, 2022 · Recall initiated: April 1, 2022

Summary

FDA records drug Class III recall D-0752-2022, published April 13, 2022 and initiated April 1, 2022. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 19,222 Bottles (100-count); Lot: Lot # 21 P0322, Exp. 01/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot # 21 P0322, Exp. 01/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06 recalled?

Yes. FDA published recall D-0752-2022 on April 13, 2022. Reported hazard: Subpotent

What should I do if I have this product?

Voluntary: Firm initiated · Letter